723 related articles for article (PubMed ID: 16820608)
1. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.
Boodhwani M; Nakai Y; Voisine P; Feng J; Li J; Mieno S; Ramlawi B; Bianchi C; Laham R; Sellke FW
Circulation; 2006 Jul; 114(1 Suppl):I402-8. PubMed ID: 16820608
[TBL] [Abstract][Full Text] [Related]
2. High-dose atorvastatin is associated with impaired myocardial angiogenesis in response to vascular endothelial growth factor in hypercholesterolemic swine.
Boodhwani M; Mieno S; Voisine P; Feng J; Sodha N; Li J; Sellke FW
J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1299-306. PubMed ID: 17140946
[TBL] [Abstract][Full Text] [Related]
3. Hypercholesterolemia impairs the myocardial angiogenic response in a swine model of chronic ischemia: role of endostatin and oxidative stress.
Boodhwani M; Nakai Y; Mieno S; Voisine P; Bianchi C; Araujo EG; Feng J; Michael K; Li J; Sellke FW
Ann Thorac Surg; 2006 Feb; 81(2):634-41. PubMed ID: 16427865
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin impairs the myocardial angiogenic response to chronic ischemia in normocholesterolemic swine.
Boodhwani M; Mieno S; Feng J; Sodha NR; Clements RT; Xu SH; Sellke FW
J Thorac Cardiovasc Surg; 2008 Jan; 135(1):117-22. PubMed ID: 18179927
[TBL] [Abstract][Full Text] [Related]
5. Effects of L-arginine on the endogenous angiogenic response in a model of hypercholesterolemia.
Nakai Y; Voisine P; Bianchi C; Xu SH; Feng J; Malik T; Rosinberg A; Sellke FW
Surgery; 2005 Aug; 138(2):291-8. PubMed ID: 16153439
[TBL] [Abstract][Full Text] [Related]
6. Effects of L-arginine on fibroblast growth factor 2-induced angiogenesis in a model of endothelial dysfunction.
Voisine P; Li J; Bianchi C; Khan TA; Ruel M; Xu SH; Feng J; Rosinberg A; Malik T; Nakai Y; Sellke FW
Circulation; 2005 Aug; 112(9 Suppl):I202-7. PubMed ID: 16159817
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the cardiac angiogenic response to surgical FGF-2 therapy in a Swine endothelial dysfunction model.
Ruel M; Wu GF; Khan TA; Voisine P; Bianchi C; Li J; Li J; Laham RJ; Sellke FW
Circulation; 2003 Sep; 108 Suppl 1():II335-40. PubMed ID: 12970256
[TBL] [Abstract][Full Text] [Related]
8. Normalization of coronary microvascular reactivity and improvement in myocardial perfusion by surgical vascular endothelial growth factor therapy combined with oral supplementation of l-arginine in a porcine model of endothelial dysfunction.
Voisine P; Bianchi C; Khan TA; Ruel M; Xu SH; Feng J; Li J; Malik T; Rosinberg A; Sellke FW
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1414-20. PubMed ID: 15942586
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the cardiac angiogenic response to exogenous vascular endothelial growth factor.
Voisine P; Bianchi C; Ruel M; Malik T; Rosinberg A; Feng J; Khan TA; Xu SH; Sandmeyer J; Laham RJ; Sellke FW
Surgery; 2004 Aug; 136(2):407-15. PubMed ID: 15300208
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin increases myocardial indices of oxidative stress in a porcine model of hypercholesterolemia and chronic ischemia.
Sodha NR; Boodhwani M; Ramlawi B; Clements RT; Mieno S; Feng J; Xu SH; Bianchi C; Sellke FW
J Card Surg; 2008; 23(4):312-20. PubMed ID: 18598320
[TBL] [Abstract][Full Text] [Related]
11. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.
John S; Schneider MP; Delles C; Jacobi J; Schmieder RE
Am Heart J; 2005 Mar; 149(3):473. PubMed ID: 15864218
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin increases oxidative stress and modulates angiogenesis in Ossabaw swine with the metabolic syndrome.
Elmadhun NY; Lassaletta AD; Chu LM; Liu Y; Feng J; Sellke FW
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1486-93. PubMed ID: 22995723
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK
J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915
[TBL] [Abstract][Full Text] [Related]
14. Calpain inhibition improves collateral-dependent perfusion in a hypercholesterolemic swine model of chronic myocardial ischemia.
Sabe AA; Potz BA; Elmadhun NY; Liu Y; Feng J; Abid MR; Abbott JD; Senger DR; Sellke FW
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):245-52. PubMed ID: 26478238
[TBL] [Abstract][Full Text] [Related]
15. Exercise training enhances vasodilation responses to vascular endothelial growth factor in porcine coronary arterioles exposed to chronic coronary occlusion.
Fogarty JA; Muller-Delp JM; Delp MD; Mattox ML; Laughlin MH; Parker JL
Circulation; 2004 Feb; 109(5):664-70. PubMed ID: 14769688
[TBL] [Abstract][Full Text] [Related]
16. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.
Sanguigni V; Pignatelli P; Lenti L; Ferro D; Bellia A; Carnevale R; Tesauro M; Sorge R; Lauro R; Violi F
Circulation; 2005 Feb; 111(4):412-9. PubMed ID: 15687128
[TBL] [Abstract][Full Text] [Related]
17. Effects of atorvastatin on circulating CD34+/CD133+/ CD45- progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus.
Jaumdally RJ; Goon PK; Varma C; Blann AD; Lip GY
J Intern Med; 2010 Apr; 267(4):385-93. PubMed ID: 19754853
[TBL] [Abstract][Full Text] [Related]
18. Effects of atorvastatin on arterial endothelial function in coronary bypass surgery.
Chello M; Goffredo C; Patti G; Candura D; Melfi R; Mastrobuoni S; Di Sciascio G; Covino E
Eur J Cardiothorac Surg; 2005 Dec; 28(6):805-10. PubMed ID: 16274999
[TBL] [Abstract][Full Text] [Related]
19. Molecular indices of apoptosis after intermittent blood and crystalloid cardioplegia.
Feng J; Bianchi C; Sandmeyer JL; Li J; Sellke FW
Circulation; 2005 Aug; 112(9 Suppl):I184-9. PubMed ID: 16159813
[TBL] [Abstract][Full Text] [Related]
20. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function.
Wassmann S; Faul A; Hennen B; Scheller B; Böhm M; Nickenig G
Circ Res; 2003 Oct; 93(9):e98-103. PubMed ID: 14551237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
